Literature DB >> 21157541

Intractable epilepsy: relapsing, remitting, or progressive?

Susan Herman.   

Abstract

Entities:  

Year:  2010        PMID： 21157541      PMCID： PMC3001022          DOI： 10.1111/j.1535-7511.2010.01383.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  10 in total

1.  Results of treatment changes in patients with apparently drug-resistant chronic epilepsy.

Authors:  Anna L Luciano; Simon D Shorvon
Journal:  Ann Neurol       Date:  2007-10       Impact factor: 10.422

2.  Likelihood of seizure remission in an adult population with refractory epilepsy.

Authors:  Brian C Callaghan; Kishlay Anand; Dale Hesdorffer; W Allen Hauser; Jacqueline A French
Journal:  Ann Neurol       Date:  2007-10       Impact factor: 10.422

Review 3.  Surgical outcomes in lesional and non-lesional epilepsy: a systematic review and meta-analysis.

Authors:  José F Téllez-Zenteno; Lizbeth Hernández Ronquillo; Farzad Moien-Afshari; Samuel Wiebe
Journal:  Epilepsy Res       Date:  2010-03-15       Impact factor: 3.045

4.  Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study.

Authors:  Matti Sillanpää; Dieter Schmidt
Journal:  Brain       Date:  2006-01-09       Impact factor: 13.501

5.  Seizure reduction and quality of life improvements in people with epilepsy.

Authors:  Gretchen L Birbeck; Ron D Hays; Xinping Cui; Barbara G Vickrey
Journal:  Epilepsia       Date:  2002-05       Impact factor: 5.864

6.  Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.

Authors:  Patrick Kwan; Alexis Arzimanoglou; Anne T Berg; Martin J Brodie; W Allen Hauser; Gary Mathern; Solomon L Moshé; Emilio Perucca; Samuel Wiebe; Jacqueline French
Journal:  Epilepsia       Date:  2009-11-03       Impact factor: 5.864

7.  Quantifying the response to antiepileptic drugs: effect of past treatment history.

Authors:  Yitzhak Schiller; Yussef Najjar
Journal:  Neurology       Date:  2008-01-01       Impact factor: 9.910

8.  How long does it take for partial epilepsy to become intractable?

Authors:  A T Berg; J Langfitt; S Shinnar; B G Vickrey; M R Sperling; T Walczak; C Bazil; S V Pacia; S S Spencer
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

9.  Seizure remission and relapse in adults with intractable epilepsy: a cohort study.

Authors:  Hyunmi Choi; Gary Heiman; Dionysis Pandis; Julio Cantero; Stanley R Resor; Frank G Gilliam; W Allen Hauser
Journal:  Epilepsia       Date:  2008-04-10       Impact factor: 5.864

Review 10.  Identification of pharmacoresistant epilepsy.

Authors:  Anne T Berg
Journal:  Neurol Clin       Date:  2009-11       Impact factor: 3.806
  10 in total
  2 in total

1.  Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy.

Authors:  Chitra Rawat; Rintu Kutum; Samiksha Kukal; Ankit Srivastava; Ujjwal Ranjan Dahiya; Suman Kushwaha; Sangeeta Sharma; Debasis Dash; Luciano Saso; Achal K Srivastava; Ritushree Kukreti
Journal:  Sci Rep       Date:  2020-02-13       Impact factor: 4.379

Review 2.  Cortical GABAergic Interneuron/Progenitor Transplantation as a Novel Therapy for Intractable Epilepsy.

Authors:  Qian Zhu; Janice R Naegele; Sangmi Chung
Journal:  Front Cell Neurosci       Date:  2018-06-26       Impact factor: 5.505
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.